FDA Warning Letter — EyePoint US, Inc.
The FDA took a Warning Letter action against EyePoint US, Inc. on July 12, 2024 (Watertown, MA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- EyePoint US, Inc.
- Date
- July 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Watertown, MA (United States)